Drug class
Fluoroquinolone antibacterial; DNA gyrase and topoisomerase IV inhibitor
Mechanism of action
Inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication, transcription and repair, producing bactericidal activity against susceptible Gram-positive and Gram-negative organisms.
General use cases
- Treatment of acute bacterial skin and skin-structure infections in adults caused by susceptible bacteria, including MRSA
- Treatment of community-acquired bacterial pneumonia in adults caused by susceptible pathogens under the applicable product label
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
